New directions in bariatric and metabolic surgery

Česká verzia

Authors: Martin Fried
Authors place of work: 1. chirurgická klinika – klinika hrudní, břišní a úrazové chirurgie 1. LF UK a VFN v Praze ; OB klinika, a. s., Praha
Published in the journal: Čas. Lék. čes. 2017; 156: 314-318
Category: Přehledové články

Summary

Czech Republic may be counted among the leading European Countries in regards of the level of delivered high quality multidisciplinary care in treatment of obesity and obesity related metabolic diseases. The 1^st Faculty of Medicine (Charles University) and the Faculty General Hospital in Prague played the most important role in the development of bariatric and metabolic surgery in the Czech Republic. pCzech bariatric surgery achieves great successes both on national and international levels. Just to mention some of them: M. Fried and M. Pešková were among the very first worldwide to implant the non-adjustable gastric banding laparoscopically in 1993, the Czech Republic was among the seven Countries to establish the International Federation for the Surgery of Obesity /IFSO/ (Fried in 1995), to organize the first IFSO World Congress in Prague (1996), to co-establish the IFSO-European Chapter in Prague (2004), to implant the first SAGB VC worldwide (Fried, Doležalová, 2007), to organize the first European Workshop on Gastric Plication (Fried, Doležalová, 2010), to co-lead development of the European Interdisciplinary Guidelines on Metabolic and Bariatric Surgery (Fried et al.,2013), and many others. In the beginning of bariatric surgery, the almost only indication criterion for operation was the criterion of weight loss. On the turn of the Century metabolic surgery gradually gained importance. The most important indication criterion for metabolic operations started to be improvement and/or resolution of obesity related co-morbidities, such as type 2 diabetes mellitus. Thus, the criterion of successful treatment shifted from weight loss towards improvement and resolution of metabolic diseases regardless the body mass index. In conjunction with importance of metabolic surgery, more emphasis is given to lowering the invasiveness of so far available minimally invasive/laparoscopic approaches form the perioperative perspective as well as from the anatomically sparing/reversible surgeries.

Keywords:
multidisciplinary cooperation, obesity, therapy, bariatric surgery, metabolic surgery

Zdroje

1. Hainer V et al. Základy klinické obezitologie. Grada, Praha, 2004.

2. Svačina Š, Bretšnajdrová A. Obezita a diabetes. Maxdorf, Praha, 2000.

3. Fried M, Yumuk V, Oppert JM et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Facts 2013; 6 : 449–468.

4. Svačina Š. Obezitologie a teorie metabolického syndromu. Triton, Praha, 2013.

5. Fried M, Pešková M, Kasalický M. Assessment of the outcome of laparoscopic nonadjustable gastric banding and stoma adjustable gastric banding: Surgeon’s and patient's view. Obesity Surgery 1998; 8 : 45–48.

6. Fried M, Pešková M, Kasalický M. The role of laparoscopy in the treatment of morbid obesity. Obesity Surgery 1998; 8 : 520–523.

7. Mechanick JI, Youdim A, Jones DB et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient –⁠ 2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract 2013; 19(2): 337–372.

8. Buchwald H, Varco RL. Metabolic Surgery. Grune & Stratton, 1978.

9. Pories W. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222 : 339–352.

10. Doležalová K, Buchwald JN, Skochová D et al. Five-year outcomes: laparoscopic greater curvature plication for treatment of morbid obesity. Obes Surg 2017; 27(11): 2818–2828.

11. Fried M, Doležalová K, Chambers AP et al. A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway. BMJ Open Diab Res Care 2017; 5: e000431.

12. Sjöström CD, Lissner L, Wedel H, Sjöström L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7 : 477–484.

Štítky

Adiktológia Alergológia a imunológia Angiológia Audiológia a foniatria Biochémia Dermatológia Detská gastroenterológia Detská chirurgia Detská kardiológia Detská neurológia Detská otorinolaryngológia Detská psychiatria Detská reumatológia Diabetológia Farmácia Chirurgia cievna Algeziológia Dentální hygienistka

Článek Glykemická variabilita a mikrovaskulární komplikace diabetu

Článek Úvodem

Článek Kam směřuje diabetologie?

Článek Kam míří technologie v diabetologii?

Článek Hyperlipoproteinemie a (nejen) ateroskleróza: střípky z historie i současnosti

Článek Postavení farmakoterapie v současné péči o obézní

Článek Incidence diabetu z pohledu dávek systému sociálního zabezpečení

Článek Tzv. protikuřácký zákon a poskytovatelé zdravotních služeb

Článek Biomarkery v onkologii: nové horizonty a výzvy v diagnostice a léčbě onkologických onemocnění ISOBM – 44. kongres Mezinárodní společnosti pro onkologii a biomarkery

Článek Nobelovy ceny za fyziologii a lékařství v letech 1940–1960

Článek Životní výročí prof. MUDr. Štěpána Svačiny, DrSc., MBA

Článek Doc. MUDr. Radana Neuwirtová, CSc., se dožívá 90 let